Lol... always someone someone seen the half empty glass of water instead of half full. These are great results guys in any FDA review panel..., great job INO. Big milestone.
Glad they are developing a test to determine who will respond, because it only a small percent of patients that will respond. I wonder if response rate is this low on their other DNA drugs/vaccines? IMO - very, very poor.